Literature DB >> 8816936

Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco.

C J Smith1, S C McKarns, R A Davis, S D Livingston, B R Bombick, J T Avalos, W T Morgan, D J Doolittle.   

Abstract

Cigarette smokers have been reported to void urine which is more mutagenic, as measured in the Ames assay, than urine voided by non-smokers. Condensate from the mainstream smoke of a cigarette which primarily heats tobacco (test cigarette) has shown significantly reduced mutagenicity in a battery of in vitro genotoxicity assays compared with tobacco-burning cigarettes. The objective of this study was to determine whether the reduction in mutagenic activity observed in the in vitro assays would be reflected in the urine of smokers of the test cigarette. Twenty smokers were enrolled in a 4-week crossover study, with each smoker consuming test cigarettes ad libitum for a week and their usual brand of tobacco-burning cigarettes the other 3 weeks. Diet was strictly controlled throughout the study, and broiled and pan-fried meat was not served to minimize ingestion of mutagenic protein pyrolysis products. There was no statistically significant difference (p = 0.06) in consumption of tobacco-heating and tobacco-burning cigarettes. There were no statistically significant differences (p = 0.22) in salivary cotinine concentrations for smokers when smoking either tobacco-burning or tobacco-heating cigarettes. Urinary nicotine (ng/mg creatinine) was not different (p = 0.31) for smokers when smoking either tobacco-burning or tobacco-heating cigarettes. Urinary cotinine (ng/mg creatinine) was 32% lower (p = 0.0004) when smoking tobacco-heating cigarettes as compared with smoking tobacco-burning cigarettes. Twenty-four-hour urine samples were collected twice weekly, concentrated using XAD-2 resin and tested in Ames strains TA98 and YG1024 with metabolic activation. Tobacco-burning cigarette smokers experienced a 79% reduction in urinary mutagenicity as measured in strain YG1024 and a 72% reduction as measured in strain TA98 during the week that they smoked the tobacco-heating cigarette while maintaining a fixed dietary regimen. The results of this study indicate that smokers of tobacco-heating cigarettes void urine which is significantly less mutagenic than urine voided by smokers of tobacco-burning cigarettes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816936     DOI: 10.1016/s0165-1161(96)90222-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  11 in total

1.  Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.

Authors:  Medjda Bellamri; Lihua Yao; Radha Bonala; Francis Johnson; Linda B Von Weymarn; Robert J Turesky
Journal:  Arch Toxicol       Date:  2019-06-15       Impact factor: 5.153

2.  Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit.

Authors:  K O Fagerström; J R Hughes; T Rasmussen; P W Callas
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 3.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 4.  Developing the science base for reducing tobacco harm.

Authors:  Dorothy K Hatsukami; Anne M Joseph; Mark Lesage; Joni Jensen; Sharon E Murphy; Paul R Pentel; Michael Kotlyar; Eugene Borgida; Chap Le; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

5.  Method for Biomonitoring DNA Adducts in Exfoliated Urinary Cells by Mass Spectrometry.

Authors:  Byeong Hwa Yun; Medjda Bellamri; Thomas A Rosenquist; Robert J Turesky
Journal:  Anal Chem       Date:  2018-07-30       Impact factor: 6.986

6.  Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry.

Authors:  Jingshu Guo; Peter W Villalta; Christopher J Weight; Radha Bonala; Francis Johnson; Thomas A Rosenquist; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2018-11-19       Impact factor: 3.739

7.  Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach.

Authors:  Evan O Gregg; Emmanuel Minet; Michael McEwan
Journal:  Biomarkers       Date:  2013-07-31       Impact factor: 2.658

Review 8.  Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective.

Authors:  Frazer J Lowe; Karsta Luettich; Evan O Gregg
Journal:  Biomarkers       Date:  2013-03-27       Impact factor: 2.658

9.  A comparative assessment of cigarette smoke aerosols using an in vitro air-liquid interface cytotoxicity test.

Authors:  David Thorne; Annette Dalrymple; Deborah Dillon; Martin Duke; Clive Meredith
Journal:  Inhal Toxicol       Date:  2015-09-04       Impact factor: 2.724

10.  Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.

Authors:  Michael W Ogden; Kristin M Marano; Bobbette A Jones; Walter T Morgan; Mitchell F Stiles
Journal:  Biomarkers       Date:  2015-11-10       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.